From crystallographers' beards to billion-dollar lawsuits, the phenomenon of disappearing polymorphs has puzzled chemists for decades. Now researchers are finally unravelling the science behind why st ...

By John Vandermosten, CFA NASDAQ: RVPH On behalf of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), Chief Executive Officer, Dr. Laxminarayan Bhat, composed a letter to shareholders ...

In this Atomic Heart Blood on Crystal DLC 4 Review, we finally got to play and finish Mundfish's final Chapter of Atomic Heart's ...

The Amazing Digital Circus stars a chaotic game master messing with his players' heads, and this fanmade TTRPG captures that ...

Laughing Water Capital highlights Theravance Biopharma as a special situation with significant upside potential. Read the ...

Here are all the biggest Xbox reveals from the Galaxies Spring Showcase 2026: ...

Welcome to our fourth issue of 2026 of The Health Record -- our healthcare law insights e-newsletter. In this edition, we look ...

Necesse blends a bit of many genres and now many collabs all in one in the Secrets update that's out now. A game that's kind ...

Here's everything announced and revealed during The Galaxies Spring Showcase 2026, including Echoes of Aincrad, Hell Let ...

Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can ...

Laughing Water Capital returned -4.5% in Q1 2026 while highlighting new high-conviction positions in Stride and Theravance.

Munich, Germany, April 23, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and ...